CLINICAL_TRIALS
trial_result
· 2012-06-01
Clinical Trial Update: A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma [Phase 2]
Summary
A Phase 2 trial assessed the safety and efficacy of CNTO 148 for severe persistent asthma, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2012-06-01